Autor Deborah M.

CIK 00018846713 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001884671

Recent Transactions

33 trades

Exercise/Conversion
Hims & Hers Health, Inc.$HIMS
Class A Common Stock
2026-03-13+32,919→ 39,094 total
Exercise/Conversion
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2026-03-13−32,919→ 493,792 total
Tax Payment
Hims & Hers Health, Inc.$HIMS
Class A Common Stock
2026-03-13$24.77/sh−11,312→ 27,782 total
Award
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2026-03-11+526,711→ 526,711 total
Sale
Hims & Hers Health, Inc.$HIMS
Class A Common Stock
2025-12-17$36.71/sh−7,054→ 6,175 total
Exercise/Conversion
Hims & Hers Health, Inc.$HIMS
Class A Common Stock
2025-12-15+7,054→ 13,229 total
Exercise/Conversion
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2025-12-15−7,054→ 14,110 total
Award
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2025-08-06+3,656→ 3,656 total
Exercise/Conversion
Hims & Hers Health, Inc.$HIMS
Class A Common Stock
2025-06-12+6,175→ 6,175 total
Exercise/Conversion
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2025-06-12−6,175→ 0 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-05-06+34,819→ 34,819 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-05-05−40,258→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-05-05+40,258→ 93,660 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-11-22$8.34/sh−33,229→ 53,402 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-11-21$8.41/sh−6,771→ 86,631 total
Award
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2024-11-15+21,164→ 21,164 total
Award
Hims & Hers Health, Inc.$HIMS
Restricted Stock Unit
2024-11-15+6,175→ 6,175 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-05-17$6.73/sh−23,447→ 93,402 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-05-16$6.76/sh−14,553→ 116,849 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-05-10−76,453→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-05-10+76,453→ 131,402 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-05-02+40,258→ 40,258 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−75,000→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−70,390→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−37,500→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−37,500→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-07-30+54,949→ 54,949 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-07-30−54,949→ 0 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-06-01+37,500→ 37,500 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-05-09+76,453→ 76,453 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2022-07-29+54,949→ 54,949 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2022-06-08+37,500→ 37,500 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2021-12-23+75,000→ 75,000 total

Companies

Recent Filings

Address

2269 CHESTNUT STREET, #523

SAN FRANCISCO, CA, 94123

View on SEC.gov